Transvaginal Ultrasound As Predictors of Successful Induction of Labour
NCT ID: NCT04477226
Last Updated: 2020-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
294 participants
OBSERVATIONAL
2019-01-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cervical Gland Area as a Predictor of Success of Labour Induction
NCT04416022
Detection of Preterm Labour by Cervical Length
NCT04104984
Bishop Score and Transvaginal Ultrasound for Preinduction Cervical Assessment in Multiparas
NCT01317823
Cervical Sliding Sign to Predict Outcome of Induction of Labor
NCT06324279
Comparison Between Ultrasonographic Cervical Length and Bishop Score in Preinduction Cervical Assessment
NCT01317706
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transvaginal ultrasound scan
Transvaginal ultrasound is done to measure the cervical length, as per Fetal Medicine Foundation guidelines
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton live pregnancy
* Gestational age between 37 - 42 weeks
* Cephalic presentation
* Intact membranes
* Reactive cardiotocograph tracing
* Low risk pregnancy
Exclusion Criteria
* Low lying placenta, placenta praevia and vaginal bleeding
* Multiple pregnancy
* Preterm Prelabour rupture of membrane/ prelabour rupture of membranes
* Known allergy towards prostaglandins
* Intrauterine fetal death
* Known fetal anomaly
* Estimated fetal weight \>3.8kg by scan
* Grandmultiparity (more than 5)
* BMI \>40kg/m2
* Diabetes and hypertension on treatment
* Other medical illness on treatment
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universiti Kebangsaan Malaysia Medical Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kah Teik Chew
Role: PRINCIPAL_INVESTIGATOR
UKMMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universiti Kebangsaan Malaysia Medical Centre
Kuala Lumpur, , Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FF-2019-368
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.